Oura postponed its $2.2bn Nasdaq IPO on pricing day after its shares reportedly looked set to sell at the bottom of their $40-to-$44 range. Even $40 a share would have valued the profitable ring maker near $14.2bn, above its 2025 private round, so the dispute is over how far above.
Perspective Coverage
4 publishers
- Builder
- Builder 9%
- Operator
- Operator 17%
- Investor
- Investor 74%
Reality
- Evidence68
- Adoption50
- Hype gap+25
- Incentives60
- Confidence62
Oura is selling 13.5 million of the 50 million shares on offer, so about $594m of the base deal reaches the company and 73% of it goes to people who already own stock. The subscription is what is being priced.
Reality
- Evidence72
- Adoption68
- Hype gap+14
- Incentives82
- Confidence64
Apple will put a 0-to-10 readiness score on the Watch Series 12 and Ultra 4, a metric Oura has kept central since its 2015 Kickstarter. The score depends on battery life, and that is where Oura still leads.
Reality
- Evidence42
- Adoption28
- Hype gap+24
- Incentives55
- Confidence45
The Ring 3 Pro carries the FDA-cleared ECG and the extra 0.43mm of thickness that comes with it, while the Slim keeps tap-to-pay and drops the sensor to stay slim. Neither has a price, and neither is expected before 2027.
Reality
- Evidence35
- Adoption6
- Hype gap+45
- Incentives70
- Confidence45
A September listing with a large secondary component would price the smart ring maker about 47% above last year's private mark. Revenue and membership numbers are still undisclosed.
Reality
- Evidence42
- Adoption30
- Hype gap+34
- Incentives72
- Confidence55
A proposed class action puts a marketing number on trial rather than a device. Any wearable that quantified inference against a sleep lab carries the same exposure.
Perspective Coverage
3 publishers
- Builder
- Builder 30%
- Operator
- Operator 38%
- Investor
- Investor 32%
Reality
- Evidence64
- Adoption58
- Hype gap+24
- Incentives74
- Confidence66